[Pharmacokinetic and clinical evaluation of imipenem/cilastatin sodium in neonates and premature infants. A study of imipenem/cilastatin sodium by a perinatal co-research group].

No abstract is available for this paper.

• Publication year

  1989

• Venue

  The Japanese Journal of Antibiotics

• Publication date

  1989-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.11553/ANTIBIOTICS1968B.42.953PMID 2671429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of the mammalian beta-lactamase renal dipeptidase (dehydropeptidase-I) by (Z)-2-(acylamino)-3-substituted-propenoic acids.

  1987cited by this paper
• Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.

  1986cited by this paper
• Single-dose pharmacokinetics of imipenem-cilastatin in neonates

  1985cited by this paper
• Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

  1979cited by this paper

• Impact of hospital formulary intervention on carbapenem use: a segmented time-series analysis of consumption and a propensity score-matched non-inferiority study of treatment efficacy

  2025cites this paper
• Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates

  2017cites this paper
• Safe use of imipenem/cilastatin in a neonatal intensive care unit

  1998cites this paper
• Change of renal function during vancomycin therapy in extremely low birthweight infants

  1996cites this paper
• Treatment of septicemia with imipenem/cilastatin sodium in very-low birth weight infants

  1996cites this paper